Centene (NYSE:CNC) will be issuing its quarterly earnings data before the market opens on Tuesday, April 24th. Analysts expect the company to announce earnings of $1.61 per share for the quarter. Centene has set its FY18 guidance at $6.95-7.35 EPS.
Centene (NYSE:CNC) last announced its earnings results on Tuesday, February 6th. The company reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. The business had revenue of $12.81 billion for the quarter, compared to the consensus estimate of $12.25 billion. Centene had a net margin of 1.71% and a return on equity of 13.68%. Centene’s quarterly revenue was up 7.5% on a year-over-year basis. During the same period last year, the firm posted $1.19 earnings per share. On average, analysts expect Centene to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.
Shares of CNC opened at $109.92 on Tuesday. The company has a market capitalization of $18,691.07, a P/E ratio of 21.85, a P/E/G ratio of 1.02 and a beta of 0.75. The company has a current ratio of 0.93, a quick ratio of 0.93 and a debt-to-equity ratio of 0.68. Centene has a 1-year low of $70.25 and a 1-year high of $112.42.
In other news, EVP Christopher D. Bowers sold 4,800 shares of the firm’s stock in a transaction that occurred on Monday, March 12th. The shares were sold at an average price of $102.27, for a total value of $490,896.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Robert K. Ditmore sold 8,750 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $104.13, for a total transaction of $911,137.50. The disclosure for this sale can be found here. 3.00% of the stock is currently owned by company insiders.
CNC has been the topic of a number of recent analyst reports. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $125.00 target price on shares of Centene in a research note on Monday, April 2nd. Oppenheimer increased their price target on shares of Centene from $111.00 to $122.00 and gave the company an “outperform” rating in a research report on Wednesday, December 20th. ValuEngine upgraded shares of Centene from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Zacks Investment Research upgraded shares of Centene from a “hold” rating to a “strong-buy” rating and set a $117.00 price target on the stock in a research report on Tuesday, December 26th. Finally, Citigroup reiterated an “outperform” rating and set a $130.00 price target (up from $122.00) on shares of Centene in a research report on Wednesday, February 7th. Four analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. Centene currently has a consensus rating of “Buy” and a consensus target price of $110.28.
COPYRIGHT VIOLATION WARNING: “Centene (CNC) Scheduled to Post Earnings on Tuesday” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/04/17/centene-cnc-scheduled-to-post-earnings-on-tuesday.html.
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs.
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.